Table 1.
Characteristics of the patients with ALCAPA
| Number | Age (months)/gender | Weight (kg) | LCA origin from PA | Preoperative Z-score of LVEDD | Preoperative MVR | Preoperative LVEF (%) | Concomitant anomalies | Other information |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.5/male | 5.0 | Right posterior near bifurcation | 3.52 | Moderate | 58 | PFO | ECMO |
| 2 | 1.7/female | 4.3 | Left posterior | 3.80 | Mild | 48 | PFO | Serial echo follow-up |
| 3 | 2.0/male | 4.6 | Right posterior | 5.55 | Mild | 50 | N | Serial echo follow-up |
| 4 | 3.0/male | 5.0 | Left-facing sinus | 5.60 | Moderate | 27 | PFO | ECMO Serial echo follow-up |
| 5 | 3.2/male | 4.8 | Right pulmonary artery | 3.39 | Mild | 42 | CoA | Serial echo follow-up |
| 6 | 3.5/female | 5.0 | Left posterior | 7.12 | Severe | 30 | N | Serial echo follow-up |
| 7 | 4.0/female | 5.8 | Right posterior near bifurcation | 6.65 | Moderate | 48 | N | Serial echo follow-up |
| 8 | 4.0/male | 4.7 | Right posterior | 6.00 | Moderate | 45 | PFO | Early dead |
| 9 | 4.0/male | 6.0 | Right posterior | 3.54 | Moderate | 51 | N | Early dead |
| 10 | 4.1/female | 6.0 | Right posterior | 6.08 | Moderate | 28 | N | Lately dead |
| 11 | 4.2/male | 6.0 | Right posterior | 6.62 | Severe | 38 | PFO | Serial echo follow-up |
| 12 | 4.5/female | 5.0 | Left posterior | 7.70 | Severe | 38 | PFO | Serial echo follow-up |
| 13 | 4.8/female | 5.5 | Left posterior | 6.87 | Mild | 35 | PDA | Serial echo follow-up |
| 14 | 5.0/female | 6.0 | Left posterior | 5.21 | Moderate | 41 | PFO | Serial echo follow-up |
| 15 | 5.5/female | 5.0 | Right posterior | 6.40 | Mild | 41 | PFO | Serial echo follow-up |
| 16 | 8.0/female | 7.0 | Right posterior near bifurcation | 0.55 | Moderate | 64 | N | Serial echo follow-up |
| 17 | 12.0/female | 8.9 | Right-facing sinus | 3.67 | Severe | 55 | MVP | Serial echo follow-up |
| 18 | 14.0/female | 7.6 | Right posterior near bifurcation | 2.84 | Mild | 40 | PDA | Serial echo follow-up |
| 19 | 15.0/female | 8.9 | Right posterior | 5.25 | Moderate | 34 | N | Serial echo follow-up |
| 20 | 21.0/female | 10.0 | Right-facing sinus | 3.74 | Moderate | 67 | MVP | Serial echo follow-up |
| 21 | 29.0/male | 14.0 | Right posterior | 4.15 | Severe | 60 | N | Serial echo follow-up |
| 22 | 46.0/male | 16.0 | Left posterior | 2.52 | Moderate | 58 | N | Serial echo follow-up |
| 23 | 60.0/female | 16.0 | Posterior | 4.67 | Moderate | 43 | N | Serial echo follow-up |
| 24 | 92.0/female | 23.0 | Left-facing sinus | −0.62 | Mild | 66 | N | Echo follow-up |
| 25 | 117.0/female | 28.0 | Left-facing sinus | 1.43 | Moderate | 67 | N | Echo follow-up |
| 26 | 161.0/female | 39.0 | Right posterior | 2.65 | Moderate | 69 | N | Echo follow-up |
ECMO: Extracorporeal membrane oxygenation; LCA: Left coronary artery; LVEF: Left ventricular ejection fraction; LVEDD: Left ventricular end-diastolic diameter; MVR: Mitral valve regurgitation; PA: Pulmonary artery; PFO: Patent foramen ovale; MVP: Mitral valve prolapse; ALCAPA: Anomalous left coronary artery from the pulmonary artery; CoA: Coarctation of the aorta; PDA: Patent ductus arteriosus; N: Without other concomitant anomaly.